Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients

Pharmacogenomics

Volumn 9, Issue 11, 2008, Pages 1595-1603

  Dmitrzak Weglarz, Monika ^a   Rybakowski, Janusz K ^a   Suwalska, Aleksandra ^a   Skibinska, Maria ^a   Leszczynska Rodziewicz, Anna ^a   Szczepankiewicz, Aleksandra ^a   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

BDNF; bipolar disorder; brain derived neurotrophin factor; lithium prophylaxis; neurotrophic tyrosine receptor kinase; NTRK2; pharmacogenetics; type 2

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GENOMIC DNA; LITHIUM SALT; METHIONINE; VALINE; DNA; LITHIUM CARBONATE; TRANQUILIZER;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PROPHYLAXIS; SINGLE NUCLEOTIDE POLYMORPHISM; CLINICAL TRIAL; GENETIC EPISTASIS; GENETICS; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA; EPISTASIS, GENETIC; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKB; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 61549095014     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.11.1595     Document Type: Article

References (48)

1. Hartigan GP: The use of lithium salts in affective disorders. Br. J. Psychiatry 109, 810-814 (1963).
2. Grof P: Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Lithium: 50 years of Psychopharmacology, New Perspectives in Biomedical and Clinical Research. Birch NJ, Gallicchio VS, Becker RW (Eds). Weidner Publishing Group, CT, USA, 36-51 (1999).
3. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A: The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 3, 63-67 (2001). (Pubitemid 32492592)
4. Turecki G, Grof P, Grof E, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol. Psychiatry 6, 570-578 (2001). (Pubitemid 32772566)
5. Shaltiel G, Chen G, Manji HK: Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr. Opin. Pharmacol. 7, 22-26 (2007). (Pubitemid 46238034)
6. Hashimoto K, Shimizu E,Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Brain Res. Rev. 45, 104-114 (2004). (Pubitemid 38625738)
7. Pruunsild P, Kazantseva A, Aid T, et al. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90, 397-406 (2007). (Pubitemid 47179877)
8. Sklar P, Gabriel SB, McInnis MG, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7, 579-593 (2002).
9. Neves-Pereira M, Mundo E, Muglia P, et al. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71, 651-655 (2002). (Pubitemid 34970137)
10. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook Jr EH: Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 161, 1698-1700 (2004). (Pubitemid 39201469)
11. Geller B, Badner JA, Tillman R, et al. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 161, 1698-1700 (2004). (Pubitemid 39201469)
12. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH: Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 139, 51-53 (2005). (Pubitemid 41552298)
13. Kremeyer B, Herzberg I, Garcia J, et al. Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 435-439 (2006). (Pubitemid 44024435)
14. Mller DJ, de Luca V, Sicard T, et al. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br. J. Psychiatry 189, 317-323 (2006). (Pubitemid 44606744)
15. Tang J, Xiao L, Shu C, et al. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci. Lett. 433, 98-102 (2008).
16. Nakata K, Ujike H, Sakai A, et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 337, 17-20 (2003). (Pubitemid 36078301)
17. Oswald P, Del-Favero J, Massat I, et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 129, 34-35 (2004). (Pubitemid 38989064)
18. Skibinska M, Hauser J, Czerski PM, et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J. Biol. Psychiatry 5, 215-220 (2004). (Pubitemid 44121701)
19. Kanazawa T, Glatt SJ, Kia-Keating B, et al. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr. Genet. 17, 165-170 (2007). (Pubitemid 46716209)
20. Kunugi H, Iijima Y, Tatsumi M, et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol. Psychiatry 56, 376-378 (2004). (Pubitemid 39164523)
21. Green EK, Raybould R, Macgregor S, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over individuals from the UK. Br. J. Psychiatry 188, 21-25 (2006). (Pubitemid 43021922)
22. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J: Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord. 5, 468-472 (2003). (Pubitemid 38072252)
23. Nakagawara A, Liu XG, Ikegaki N, et al. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2). Genomics 25, 538-546 (1995).
24. Yeo GS, Connie Hung CC, Rochford J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187-1189 (2004). (Pubitemid 39426236)
25. Adams JH, Wigg KG, King N, et al. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 132, 90-95 (2005). (Pubitemid 40066203)
26. Cunha AB, Frey BN, Andreazza AC, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 398, 215-219 (2006).
27. Palomino A, Vallejo-Illarramendi A, Gonzalez-Pinto A, et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr. Res. 86, 321-322 (2006). (Pubitemid 44234056)
28. Monteleone P, Serritella C, Martiadis V, Maj M: Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 10, 95-100 (2008).
29. Manji HK, Quiroz JA, Sporn J, et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53, 707-742 (2003). (Pubitemid 39658487)
30. Gould TD, Manji HK: Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30, 1223-1237 (2005).
31. Yasuda S, Liang MH, Marinova Z, et al. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry (2007) (Epub ahead of print).
32. Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang DM: Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 80, 589-597 (2002). (Pubitemid 34809967)
33. Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144, 820-823 (2007). (Pubitemid 47417214)
34. Masui T, Hashimoto R, Kusumi I, et al. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr. Genet. 16, 49-50 (2006). (Pubitemid 44481202)
35. Michelon L, Meira-Lima I, Cordeiro Q, et al. Association study of the INPP1, 5HTT, BDNF, AP-2b and GSK-3b gene variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci. Lett. 403, 288-293 (2006). (Pubitemid 44040958)
36. Rybakowski JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol. Rep. 57, 124-127 (2005). (Pubitemid 40601550)
37. Miller SA, Dykes DD,Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1215 (1988).
38. Egan MF, Kojima M, Callicott JH, et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269 (2003). (Pubitemid 36144114)
39. Tsai SJ, Hong CJ, Yu YW, Chen TJ: Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 49, 13-16 (2004).
40. Rybakowski JK, Suwalska A, Skibinska M, et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38, 166-170 (2005). (Pubitemid 41059223)
41. Beuten J, Ma JZ, Payne TJ, et al. Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 139, 73-80 (2005). (Pubitemid 41552302)
42. Schumacher J, Jamra RA, Becker T, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58, 307-314 (2005). (Pubitemid 41133624)
43. Watanabe Y, Muratake T, Kaneko N, et al. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr. Res. 84, 29-35 (2006). (Pubitemid 44255717)
44. de Cid R, Fonseca F, Gratacs M, et al. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Genes Brain Behav. 7, 515-522 (2008). (Pubitemid 351991486)
45. Kunugi H, Ueki A, Otsuka M, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimers disease. Mol. Psychiatry 6, 83-86 (2001). (Pubitemid 32096070)
46. Vepsäläinen S, Castren E, Helisalmi S, et al. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimers disease. J. Neurol. 252(4), 423-428 (2005). (Pubitemid 40584812)
47. GraphPad software www.graphpad.com
48. Internet service Primer 3 http://frodo.wi.mit.edu/cgi-bin/primer3/ primer3-www.cgi